StockData
Bristol Myers Squibb Co logo

Bristol Myers Squibb Co

BMYNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as CELG.RI
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 15/3031% below fair value
$58.80+0.46 (+0.79%)

Close on Nov 20, 2026Market cap $120.19BP/E 13.0Yield 4.23%

Bristol Myers Squibb GAAP Cost of Products Sold by Quarter

GAAP Cost of Products Sold ($M) ($M)

Bristol Myers Squibb GAAP Cost of Products Sold: $4,146M in Q3 2026, up 20.7% from a year earlier.

Latest, Q3 2026
4,146
Period ended Sep 30, 2026
Change on a year earlier
+20.7%
3,435 in Q3 2025
History
35 quarters
Since Q1 2018
Sources
30
Documents cited below

Where the Q3 2026 figure comes from

“|| Cost of products sold | $ | 4,146 | $ | (13) | $ | 4,133 | $ | 11,292 | $ | (41) | $ | 11,252”

Source: Form 8-K (a2026q3ex991-filing.htm, filed 2026-10-29) ↗

Reported in Form 8-K GAAP to Non-GAAP Reconciliation.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedGAAP Cost of Products Sold ($M) ($M)Year on yearSource
Q3 2026Sep 30, 20264,146+20.7%Form 8-K (a2026q3ex991-filing.htm, filed 2026-10-29) ↗
Q2 2026Jun 30, 20263,726+10.5%Form 8-K (a2026q2ex991-filing.htm, filed 2026-07-30) ↗
Q1 2026Mar 31, 20263,421+12.8%Form 8-K (a2026q1ex991.htm, filed 2026-04-30) ↗
Q4 2025Dec 31, 20254,097-14.9%Form 10-K (filed 2026-02-11) ↗
Q3 2025Sep 30, 20253,435+16.2%Form 8-K (a2026q3ex991-filing.htm, filed 2026-10-29) ↗
Q2 2025Jun 30, 20253,372+3.2%Form 8-K (a2026q2ex991-filing.htm, filed 2026-07-30) ↗
Q1 2025Mar 31, 20253,033+3.4%Form 8-K (a2026q1ex991.htm, filed 2026-04-30) ↗
Q4 2024Dec 31, 20244,812+75.3%Form 10-K (filed 2026-02-11) ↗
Q3 2024Sep 30, 20242,957+18.0%Form 10-Q (filed 2025-10-30) ↗
Q2 2024Jun 30, 20243,267+13.6%Form 10-Q (filed 2025-07-31) ↗
Q1 2024Mar 31, 20242,932+14.3%Form 10-Q (filed 2025-04-24) ↗
Q4 2023Dec 31, 20232,745+5.9%Form 10-K (filed 2026-02-11) ↗
Q3 2023Sep 30, 20232,506+6.5%Form 10-Q (filed 2024-10-31) ↗
Q2 2023Jun 30, 20232,876+5.7%Form 10-Q (filed 2024-07-26) ↗
Q1 2023Mar 31, 20232,566+3.8%Form 10-Q (filed 2024-04-25) ↗
Q4 2022Dec 31, 20222,593+10.1%Form 10-K (filed 2025-02-12) ↗

Cite this data

StockData. (2026). Bristol Myers Squibb GAAP Cost of Products Sold ($M), quarterly Q1 2018–Q3 2026 [Data set]. Compiled from Bristol Myers Squibb SEC filings and investor materials. https://stockdatahq.com/stocks/bmy/kpis/gaap-cogs-rec

See every metric in the Bristol Myers Squibb KPI table. Data updated Nov 3, 2026.

See a number that looks wrong?